The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.

Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...

The Department of Health and Human Services is cancelling hundreds of millions of dollars in funding pledged to Moderna to help the company develop, test, and license mRNA-based vaccines to combat ...

THURSDAY, May 29, 2025 (HealthDay News) — The U.S. government has canceled a $600 million contract with Moderna to develop a ...

The canceled contract comes as Moderna nears a critical FDA decision for its next-generation COVID-19 vaccine.

The amount of the funding cut is significant for a company of Moderna's size. It reported a total of $1 billion in sales for the fourth quarter of 2024, and expects 2025 revenue to be between $1.5 to ...

The US Department of Health and Human Services is terminating a contract with drugmaker Moderna to develop a vaccine to ...

The Trump administration’s decision to yank nearly $600 million in promised bird flu vaccine funding is the latest worrying ...

The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential ...

The Department of Health and Human Services cut over $750 million in funding for Moderna to develop an mRNA bird flu vaccine ...

The Trump administration has withdrawn $766 million in funding from Moderna, impacting the development of vaccines against ...